Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of LUM Imaging System in Breast Cancer
NCT02438358Phase 2Completed
- Sponsor
- Lumicell
- Start
- Jun 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of pegulicianine in breast cancer, sponsored by Lumicell. Started Jun 2015; status: completed.
02
Drugs
pegulicianine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02438358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438358.